{"id":"W4296663392","doi":"10.1016/j.ccell.2022.08.015","title":"MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Cell","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; National Institute of General Medical Sciences; Japan Society for the Promotion of Science; Ludwig Center at Harvard; Takeda Oncology; EMD Serono; National Institutes of Health; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Princess Takamatsu Cancer Research Fund; Revolution Medicines; Array BioPharma; Robert A. and Renee E. Belfer Family Foundation; Lilly Oncology; Boehringer Ingelheim; Takeda Pharmaceuticals U.S.A.; Takeda Science Foundation; National Cancer Institute; Foghorn Therapeutics; Gilead Sciences; Dana-Farber Cancer Institute; Japan Agency for Medical Research and Development; Uehara Memorial Foundation; Novartis; AbbVie; Northeastern University; Merck; Dana-Farber/Harvard Cancer Center; AstraZeneca; Canadian Asian Studies Association; Expect Miracles Foundation","keywords":"Cancer research; Intracellular; Apoptosis; Programmed cell death; Biology; In vivo; Cell biology; Sting","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001586021,0.0001542253,0.0002688886,0.00006468479,0.0002445013,0.000005546183,0.0001998488,0.00009028819,0.02055754],"category_scores_gemma":[0.000009384694,0.0001500765,0.0001372181,0.0001270186,0.0001262504,0.00006908311,0.0002119355,0.0003015084,0.00003313186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003687133,"about_ca_system_score_gemma":0.0002903695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002764787,"about_ca_topic_score_gemma":0.00008614864,"domain_scores_codex":[0.998859,0.0002408606,0.0003101372,0.0002393281,0.00005102567,0.0002996658],"domain_scores_gemma":[0.9994175,0.00005368462,0.0001907041,0.0002542771,0.00007047819,0.00001328504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008666108,0.0001328696,0.0007435378,0.00005058495,0.0001422719,0.000003037495,0.0009309737,0.00005729732,0.9862511,0.000123219,0.009180342,0.001518197],"study_design_scores_gemma":[0.001082475,0.000176191,0.001085496,0.00003314456,0.00006473517,0.00001513592,0.0005966754,0.0000107242,0.9125227,0.00001038667,0.08423931,0.0001630175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9043929,0.09036567,0.00002139297,0.0001486563,0.001578799,0.0002362008,0.0003000375,0.0000404902,0.00291583],"genre_scores_gemma":[0.9883966,0.001760162,0.000006135557,0.0003151206,0.00002747009,0.0002056305,0.00006349618,0.00002127661,0.009204096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08860551,"threshold_uncertainty_score":0.9803378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008493374383985472,"score_gpt":0.2553160615356873,"score_spread":0.2468226871517018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}